129 related articles for article (PubMed ID: 12111991)
1. Nuclear matrix proteins as biomarkers in prostate cancer.
Leman ES; Getzenberg RH
J Cell Biochem; 2002; 86(2):213-23. PubMed ID: 12111991
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the nuclear matrix proteins in a transgenic mouse model for prostate cancer.
Leman ES; Arlotti JA; Dhir R; Greenberg N; Getzenberg RH
J Cell Biochem; 2002; 86(2):203-12. PubMed ID: 12111990
[TBL] [Abstract][Full Text] [Related]
3. Identification of nuclear matrix proteins in the cancer and normal rat prostate.
Getzenberg RH; Pienta KJ; Huang EY; Coffey DS
Cancer Res; 1991 Dec; 51(24):6514-20. PubMed ID: 1742724
[TBL] [Abstract][Full Text] [Related]
4. Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer.
Leman ES; Madigan MC; Brünagel G; Takaha N; Coffey DS; Getzenberg RH
J Cell Biochem; 2003 Feb; 88(3):599-608. PubMed ID: 12532335
[TBL] [Abstract][Full Text] [Related]
5. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer.
Partin AW; Getzenberg RH; CarMichael MJ; Vindivich D; Yoo J; Epstein JI; Coffey DS
Cancer Res; 1993 Feb; 53(4):744-6. PubMed ID: 7679049
[TBL] [Abstract][Full Text] [Related]
6. Bladder cancer-associated nuclear matrix proteins.
Getzenberg RH; Konety BR; Oeler TA; Quigley MM; Hakam A; Becich MJ; Bahnson RR
Cancer Res; 1996 Apr; 56(7):1690-4. PubMed ID: 8603421
[TBL] [Abstract][Full Text] [Related]
7. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of nuclear lamins in normal and cancerous prostate tissues.
Coradeghini R; Barboro P; Rubagotti A; Boccardo F; Parodi S; Carmignani G; D'Arrigo C; Patrone E; Balbi C
Oncol Rep; 2006 Mar; 15(3):609-13. PubMed ID: 16465420
[TBL] [Abstract][Full Text] [Related]
9. p300 modulates nuclear morphology in prostate cancer.
Debes JD; Sebo TJ; Heemers HV; Kipp BR; Haugen DL; Lohse CM; Tindall DJ
Cancer Res; 2005 Feb; 65(3):708-12. PubMed ID: 15705864
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
Zeng L; Kyprianou N
Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
[TBL] [Abstract][Full Text] [Related]
11. Role of the nuclear matrix proteins in malignant transformation and cancer diagnosis.
Sjakste N; Sjakste T; Vikmanis U
Exp Oncol; 2004 Sep; 26(3):170-8. PubMed ID: 15494683
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of AIbZIP and Cdc47 as markers for human prostatic diseases.
Levesque MH; El-Alfy M; Berger L; Labrie F; Labrie C
Urology; 2007 Jan; 69(1):196-201. PubMed ID: 17270658
[TBL] [Abstract][Full Text] [Related]
13. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
14. The potential role of purine-rich element binding protein (PUR) alpha as a novel treatment target for hormone-refractory prostate cancer.
Inoue T; Leman ES; Yeater DB; Getzenberg RH
Prostate; 2008 Jul; 68(10):1048-56. PubMed ID: 18386260
[TBL] [Abstract][Full Text] [Related]
15. A common set of nuclear matrix proteins in prostate cancer cells.
Pienta KJ; Lehr JE
Prostate; 1993; 23(1):61-7. PubMed ID: 8337186
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: identification of differentially expressed and MAR-binding proteins.
Barboro P; D'Arrigo C; Repaci E; Bagnasco L; Orecchia P; Carnemolla B; Patrone E; Balbi C
Exp Cell Res; 2009 Jan; 315(2):226-39. PubMed ID: 19000672
[TBL] [Abstract][Full Text] [Related]
17. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
18. Identification of nuclear matrix protein alterations associated with human colon cancer.
Brünagel G; Vietmeier BN; Bauer AJ; Schoen RE; Getzenberg RH
Cancer Res; 2002 Apr; 62(8):2437-42. PubMed ID: 11956108
[TBL] [Abstract][Full Text] [Related]
19. Improving the value of fine needle aspiration biopsy of the prostate.
Buhmeida A; Collan Y
Pathologica; 2001 Jun; 93(3):242-3. PubMed ID: 11433620
[No Abstract] [Full Text] [Related]
20. Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications.
Barboro P; Rubagotti A; Boccardo F; Carnemolla B; Darrigo C; Patrone E; Balbi C
Anticancer Res; 2005; 25(6B):3999-4004. PubMed ID: 16309191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
